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Edited by Veli-Pekka LehtoAbstract The potential role of cysteine cathepsins, especially
cathepsin B, in Fas/CD95-induced apoptosis was investigated
using wild-type and cathepsin B-deﬁcient primary skin ﬁbro-
blasts. Apoptosis was induced with an anti-Fas/CD95 antibody
in the presence of cycloheximide and no diﬀerence was observed
between the two genotypes. First cells with damaged mitochon-
dria were observed 3 h post apoptosis induction and their num-
ber was signiﬁcantly increased after 11 h. In contrast, cells with
damaged lysosomes were only seen after 15 h with no diﬀerence
between the two genotypes. Moreover, Bid cleavage was found to
be diminished in cathepsin B-deﬁcient cells. These results suggest
that cysteine cathepsins have no active role in Fas/CD95 apopto-
sis.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Fas/CD95 (APO-1) is one of the best characterized receptors
from the tumor necrosis factor (TNF) receptor family with a
major role in induction of apoptosis [1]. It has been found to
be implicated in T- and B-cell apoptosis, in liver homeostasis
and in a number of malignancies [2]. The mechanism of cell
death triggered by Fas/CD95 is intimately linked with the for-
mation of the death inducing signalling complex (DISC),
which in addition to the receptor and its ligand involves the
adaptor protein Fas-associated death domain containing pro-
tein (FADD) and the apoptosis-initiating protease caspase-8,
which binds to FADD through DED and gets activated in
the complex through proximity-induced dimerization [3]. The
pathways downstream of caspase-8 activation diﬀer based on
the quantity of active caspase-8 formed. In type I cells, such
as thymocytes, high amounts of caspase-8 are suﬃcient to di-
rectly activate the executioner caspases, in particular caspase-
3, whereas in type II cells, such as hepatocytes, the level of cas-
pase-8 formed is insuﬃcient for direct caspase-3 activation and
requires engagement of the mitochondrial system through the*Corresponding author. Fax: +386 1 477 3984.
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doi:10.1016/j.febslet.2007.10.005cleavage of proapoptotic Bcl-2 homologue Bid and subsequent
release of proapoptotic factors from mitochondria [1,4–6].
In addition to caspases, the cathepsins [7], which have tradi-
tionally been viewed as lysosomal mediators of protein turn-
over, have been found to be implicated in apoptosis [8–10].
Lysosome-mediated apoptosis results from a destabilization
of the lysosomal membrane followed by the release of cathep-
sins into the cytosol. Although lysosomes were found to be
particularly sensitive towards oxidative stress [11,12], lyso-
somal destabilization was observed during apoptosis induced
by diﬀerent stimuli, including death ligands from the TNF
family [10,13,14]. Although there is a clear picture that lyso-
somal cysteine cathepsins, in particular cathepsin B, are in-
volved in TNF-a and TRAIL-induced apoptosis [15–17], the
involvement of lysosomal proteases in Fas/CD95-induced
apoptosis is still debated. While some authors suggest that
activation of CD95 does not involve lysosomes [15,18], others
suggest the opposite [19–21].
In order to address this question, Fas/CD95-induced apop-
tosis was investigated in wild-type and cathepsin B-deﬁcient
primary murine skin ﬁbroblasts. We found that cysteine
cathepsins including cathepsin B are not involved in apoptosis
progression, although the lysosomes were found to be destabi-
lized at a later time point and the amount of Bid cleaved was
considerably diminished in cathepsin B-deﬁcient cells as com-
pared to the wild-type, suggesting that lysosomal destabiliza-
tion and cathepsin-mediated Bid cleavage are probably not
of physiological importance.2. Materials and methods
2.1. Materials
DMEM medium was purchased from Gibco BRL (Grand Island,
NY, USA). Fetal bovine serum, horseradish peroxidase-conjugated
rabbit-anti-goat IgG, cycloheximide (CHX) and protein inhibitor
cocktail were obtained from Sigma (USA). The polyclonal antibodies
against Bid were from R&D Systems (USA), the antibodies against
CD95 mAb Jo-2 were from Pharmingen BD (USA), while the en-
hanced chemiluminiscence Western blotting reagents were obtained
from Amersham Pharmacia Biotech (Stockholm, Sweden). The cas-
pase substrate acetyl-Asp-Glu-Val-Asp-7-amino-4-tri-ﬂuoromethyl
coumarin (Ac-DEVD-AFC) and the pancaspase inhibitor z-VAD-
fmk were purchased from Bachem (Switzerland). The cysteine protease
inhibitor E-64d was from Peptide Inc. (Japan). Fluorescent organelle-
speciﬁc probe Mitotracker Red CMX-Ros was from Molecular Probes
(Eugene, OR, USA) and acridine orange (AO) was from Sigma (St
Louis, MO, USA). Annexin V-PE and 7-AAD for ﬂow cytometry were
purchased from BD Biosciences (USA) and the Bradford reagent was
from Bio-Rad (Germany).blished by Elsevier B.V. All rights reserved.
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Wild-type (WT) and cathepsin B knock out (BKO) primary murine
skin ﬁbroblasts were prepared from 3-day-old wild-type or cathepsin
B-deﬁcient mice [22] as described previously [23]. Cells were grown
in DMEM medium supplemented with 10% FCS, 2 mM glutamine,
and 1000 U/ml of penicillin-streptomycin at 37 C in a humidiﬁed air
atmosphere with 5% CO2. Cells were maintained in plastic plates
and subcultivated at conﬂuence twice a week. For all experiments cells
were used at passages 2–6.
2.3. Induction of apoptosis, cell lysis and Western blotting
Cells were cultured at 1 · 106 cells/ml in 6-well plates at least 16 h be-
fore the induction of apoptosis. The cell permeable inhibitors E-64d or
z-VAD-fmk were added at the concentration of 15 lM in dimethyl-
sulfoxide (DMSO) 2 h prior to induction of apoptosis with anti-
CD95 mAb Jo-2 (0.2 lg/ml) in the presence of CHX (1 lg/ml) for
15 h, as used by others. Following apoptosis induction, cells were
collected, pelleted by centrifugation at 1300 rpm for 5 min and washed
twice with PBS. Whole-cell extracts were prepared in RIPA buﬀer
(50 mM Tris, pH 8.0, 100 mM NaCl, 0.1% (w/v) SDS, 1% (v/v) Non-
idet P-40, 0.5% (w/v) deoxycholic acid, 1 mM EDTA) containing pro-
tease inhibitor cocktail. Following 10 min incubation on ice, insoluble
material was removed by centrifugation at 14000 rpm for 10 min.
Total protein concentration was determined using the Bradford assay.
Equal amounts (50 lg) of protein were resolved in 15% SDS–PAGE
gels and electro-transferred to nitrocellulose membranes. Blots were
probed with Bid speciﬁc goat IgG antibodies at 1:500 dilution. Anti-
goat horseradish peroxidase-conjugated secondary antibodies (at
1:3000 dilution) were used, followed by visualization with ECL accord-
ing to the manufacturer’s instructions.
2.4. Flow cytometry
Phosphatidylserine exposure and the loss of membrane integrity
were measured by labeling cells with Annexin V-PE and 7-amino-acti-
nomycin D (7-AAD) according to the manufacturer’s instructions.
Cells were then subjected to FACS analysis using FACScalibur ﬂow
cytometer (Becton Dickinson, USA) and CellQuest software.
2.5. Measurement of DEVD-ase activity
For measurement of DEVD-ase activity, cellular proteins were pre-
pared as described above for Western blotting assay. Fifty micrograms
of protein were used to determine DEVD-ase activity by measuring the
proteolytic cleavage of the ﬂuorogenic substrate Ac-DEVD-AFC (Ba-
chem) by caspases, as described previously [24].2.6. Lysosomal and mitochondrial stability assessment
2.6.1. Mitochondria membrane stability assay. Change in mitochon-
drial membrane potential (DWm) was assessed by use of MitoTracker
Red CMX-Ros. MitoTracker Red CMXRos is a red-ﬂuorescent dye
that stains mitochondria in live cells and its accumulation is dependent
upon membrane potential. Cells with an increased number of damaged
mitochondria had decreased red ﬂuorescence. To determine how treat-
ment with CD95 mAb Jo-2 and CHX aﬀected mitochondrial mem-
brane stability in the primary wild-type (WT) and cathepsin B knock
out (BKO) murine skin ﬁbroblasts, cells were incubated with DMEM
medium supplemented with 30 nM MitoTracker Red CMX-Ros after
appropriate time post apoptosis induction. Following 10 min incuba-
tion at 37 C, red ﬂuorescence, corresponding to the DWm of mito-
chondria, was determined by ﬂow cytometry using the FL-3 channel
and 5000 cells per sample.
2.6.2. Lysosome membrane stability assay. Cells were assessed for
lysosomal stability using acridine orange (AO) uptake and relocation
methods. AO is a lysosomotropic, weak base (pKa = 10.3), which is re-
tained in its charged form (AOH+) inside the acidic vacuolar compart-
ment by proton trapping. Brieﬂy, cells treated with anti-CD95 mAb
Jo-2 and CHX were incubated with DMEM medium supplemented
with AO (5 lg/ml for 15 min at 37 C) after 3, 7, 11 and 15 h post
apoptosis induction. Cells displaying a reduced number of intact
AO-accumulating lysosomes, the so-called ‘pale cells’, were analyzed
as having decreased red ﬂuorescence (the AO uptake method) [25].
Red ﬂuorescence (FL-3 channel) of 5000 cells per sample was mea-
sured by ﬂow cytometry. Although LysoTracker Green DND-26
probe worked well in ﬂuorescence microscopy, the probe could not
have been used in ﬂow cytometry measurements in ﬁbroblasts, inagreement with manufacturer’s instructions (http://probes.invitro-
gen.com/handbook/print/1203.html).3. Results
3.1. Treatment with anti-CD95 mAb and CHX induced
cathepsin-independent and caspase-dependent cell death in
primary murine skin ﬁbroblasts
In order to address the role of cathepsin B and other cysteine
cathepsins in Fas/CD95 signalling pathway, the kinetics of
DEVD-ase activity, characteristic of caspase activation, and
phosphatidylserine externalization were analyzed in primary
murine skin ﬁbroblasts from wild-type and cathepsin B-deﬁ-
cient mice, treated with anti-CD95 mAb Jo-2. Stimulation of
cells with 0.2 lg/ml anti-CD95 mAb Jo-2 alone did not induce
increase in caspase activity or percentage in phosphatidylser-
ine-positive cells in any of the two genotypes of ﬁbroblasts.
However, 1 lg/ml CHX sensitized the ﬁbroblasts to anti-
CD95 mAb-induced cell death, as judged on the basis of mor-
phology changes (not shown), increased DEVD-ase activity
and increased number of apoptotic cells (Fig. 1). This is in
agreement with results on human dermal ﬁbroblasts where
Fas activation resulted in caspase-8 activation and apoptosis
only in the presence of CHX [26], and consistent with type II
cells’ behavior. However, no diﬀerence was observed between
the wild-type (WT) and cathepsin B-deﬁcient (BKO) cells
(Fig. 1), suggesting that cathepsin B is not important for cas-
pase activation and apoptosis progression in this type of cell
death. Serial passaging of ﬁbroblast cultures did not signiﬁ-
cantly modify the apoptotic susceptibility of both cell lines
to anti-CD95 mAb Jo-2 and CHX between passages 2 and 6
(data not shown), implying that the passage number has no ef-
fect on apoptosis progression.
As in addition to cathepsin B some other cysteine cathepsin
could contribute to Fas/CD95 apoptosis in murine ﬁbroblasts,
we next used the broad-spectrum cell-permeable cysteine
cathepsin inhibitor E-64d. As can be seen in Fig. 1, pretreat-
ment of ﬁbroblasts with 15 lM E-64d for 2 h prior to induc-
tion of apoptosis, which is known to completely block
cysteine cathepsin activity in cells [27], had no eﬀect on apop-
tosis progression as determined by ﬂow cytometry (Fig. 1B),
suggesting that none of the cysteine cathepsins is implicated
in Fas/CD95 apoptosis in primary skin ﬁbroblasts. In a control
experiment, preincubation of cells with 15 lM pan-caspase
inhibitor z-VAD-fmk completely abolished all signs of apopto-
sis in both genotypes, in agreement with the essential role of
caspases in this cell death model (Fig. 1). Very similar results
were obtained 18 h post apoptosis induction with slightly in-
creased number of apoptotic cells. The percentage of annexin
V/7-AAD double positive cells, indicative of late apoptotic
or necrotic cells was very low at both 15 and 18 h (5–11%;
Fig. 1B).
3.2. Fas-induced apoptosis induced mitochondrial destabilization
and is accompanied by disruption of lysosomes
Although cysteine cathepsins including cathepsin B were
found to be dispensable for Fas/CD95-induced apoptosis in
murine skin ﬁbroblasts, an earlier report suggesting that Fas
signalling induced early lysosomal destabilization [19],
prompted us to explore this possibility. In a preliminary exper-
iment, wt and cathepsin B-deﬁcient ﬁbroblasts were incubated
Fig. 1. Fas/CD95-induced apoptosis in skin ﬁbroblasts from wild-type (WT) mice and cathepsin B-deﬁcient (BKO) mice. DEVD-ase activity (A) and
the percentage of annexin V+/7-AAD+ cells (B). All experimental details are in Section 2. (A) The enzyme activity is expressed in arbitrary units. The
results are means ± S.D. of at least three independent experiments performed in duplicate. (B) The percentages of annexin V+/7-AAD+ cells are
indicated on each histogram. The results are means ± S.D. (S.D. from both annexin V and 7-AAD positive cells) of three independent experiments
performed 15 and 18 h post apoptosis induction.
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niﬁcant number of cells were found to have damaged lyso-
somes, based on the AO staining (data not shown). As in
type II cells Fas/CD95 signalling pathway leading to execu-
tioner caspase activation involves recruitment of the mitochon-
drial pathway [4], we next investigated the kinetics of
mitochondrial and lysosomal disruption. Therefore, we moni-tored in parallel the loss of DWm using Mitotracker Red
CMXRos and lysosome stability using AO uptake at 0, 3, 7,
11, and 15 h time points. As shown in Fig. 2A, the percentage
of cells with damaged mitochondria increased already after 3 h
after the treatment. A signiﬁcant number of cells with dam-
aged mitochondria was observed at 11 h time-point (>20%)
and then increased to the latest measurement after 15 h
Fig. 2. Time course of mitochondrial and lysosomal integrity in Fas/
CD95 apoptosis. Skin ﬁbroblasts from WT (A) and BKO (B) mice
were treated with anti-CD95 mAb Jo-2 (0.2 lg/ml) plus CHX (1 lg/ml)
for 0, 3, 7, 11, and 15 h. Mitotracker Red CMXRos- and AO-uptake
by WT (A) and BKO skin ﬁbroblasts (B) were determined by ﬂow
cytometry as described in Section 2.6. Each histogram indicates
mean ± S.D. of three ﬁelds of 5000 cells, and was determined from
three independent experiments.
Fig. 3. Cleavage of Bid in murine skin ﬁbroblasts in Fas/CD95
apoptosis. An equal amount of proteins was loaded and separated on
15% SDS–PAGE, followed by Western blotting with the anti-Bid
antibodies. The blot is representative of two independent experiments.
All experimental details are in Section 2.
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lized lysosomes (>30%) was only seen 15 h after the treatment,
indicating that the loss of lysosomal integrity is a late event in
Fas/CD95-induced apoptosis, substantially preceded by mito-
chondrial destabilization. Essentially the same results with no
statistically signiﬁcant diﬀerences were obtained in cathepsin
B-deﬁcient ﬁbroblasts (Fig. 2B).
3.3. The Bcl-2 family member Bid is a substrate of caspase-8 and
cathepsin B during anti-Fas-induced cell death
The proapoptotic BH3-only protein Bid is a known link be-
tween caspase-8 and mitochondria in Fas/CD95 signalling in
type II cells [6]. As in addition to caspase-8, Bid could be also
cleaved during apoptosis by cysteine cathepsins in diﬀerent cell
death models [24,28,29], the possibility that Bid might be a
substrate of cysteine cathepsins in Fas-induced apoptosis was
investigated. As can be seen, during Fas-induced apoptosis
Bid was found to be cleaved into a 15 kDa truncated variant
(tBid), which could be prevented by z-VAD-fmk in both wild-
type and cathepsin B-deﬁcient ﬁbroblasts, consistent with the
major role of caspases in this model. However, the cleavageof Bid was signiﬁcantly reduced in cathepsin B-deﬁcient ﬁbro-
blasts, suggesting that cathepsin B contributes to Bid cleavage
(Fig. 3).4. Discussion
Activation of CD95 death receptor induces apoptosis in vivo
in a number of cell types, including B- and T-cells, hepatocytes,
and lymphoid, endothelial and glomerular cells [1,2,30–32].
Fibroblasts also display surface Fas/CD95 receptors and the
role of CD95/CD95L interactions in ﬁbroblast apoptosis has
been supported by diﬀerent studies [33,34]. Here, we show that
Fas/CD95-induced apoptosis in primary murine skin ﬁbro-
blasts is not critically dependent on cysteine cathepsins,
although lysosomes were found to be destabilized at a late time
during apoptosis in both wild-type and cathepsin B-deﬁcient
cells, and the cleavage of Bid to its activated form was found
to be diminished in cathepsin B-deﬁcient cells.
Despite the increasing number of reports implicating cys-
teine cathepsins in cell death processes, there is still no clear
understanding of the mechanisms involved [14,29,35,36]. There
is still a major debate, whether they can be critically involved
in apoptosis also in the absence of caspases [35] or they have
a more subtle role, which is limited to assistance in caspase
activation [29]. So far, Bid is one of the very few identiﬁed
cellular substrates of cysteine cathepsins in apoptosis, suggest-
ing that they are involved in the engagement of mitochondrial
system in several cell death models [24,37,38]. Since in type I
cells Fas/CD95 apoptosis is very rapid and mitochondria are
dispensable [4], it can be suggested that lysosomes, which were
shown to be destabilized very late and substantially after the
mitochondria, would not have a function in Fas-pathway in
these cells. On the other hand, involvement of mitochondria
in Fas/CD95-induced apoptosis is mandatory in type II cells.
In agreement with this, mitochondria in primary skin ﬁbro-
blasts start to loose membrane potential 3 h post apoptosis
induction. The very late lysosomal destabilization as compared
to mitochondria breakdown suggests that, similarly to type I
cells, lysosome destabilization is not really important for apop-
L. Bojicˇ et al. / FEBS Letters 581 (2007) 5185–5190 5189tosis progression in type II cells. The breakdown of lysosomes
observed (Fig. 2) can at least partially support the results of
Brunk et al. demonstrating that Fas-induced apoptosis is
accompanied by lysosomal destabilization [20]. However, our
results show that lysosome destabilization is a very late event
in Fas/CD95 induced apoptosis and not an early event, as sug-
gested by Brunk and Svensson [19], although this may depend
on cells or cell line used. Despite the very late appearance of
cells with destabilized lysosomes, our results do not support
the idea that secondary necrosis is responsible for lysosome
breakdown [39], as only 5–11% of late apoptotic/necrotic cells
were observed even at the latest time point (18 h), whereas 30–
35% of cells with destabilized lysosomes have been found al-
ready after 15 h (Figs. 1 and 2). However, these results lead
to a conclusion that the physiological signiﬁcance of lysosomal
destabilization in Fas-induced apoptosis is questionable.
Although cysteine cathepsins, in particular cathepsin B,
which are the most abundant lysosomal proteases, were found
to be involved in TNF-a and TRAIL-induced apoptosis [15–
17], no such ﬁndings could be demonstrated in Fas-induced
apoptosis. Instead, the complete lack of eﬀect of cysteine
cathepsins on the progression of apoptosis is in agreement with
earlier results on hepatocytes, which are also type II cells
[18,39], suggest that cysteine cathepsins are not actively in-
volved in Fas-induced apoptosis. In line with these observa-
tions is also the questionable physiological signiﬁcance of
Bid cleavage by cathepsin B. Although a signiﬁcant amount
of Bid was found to be cleaved by cathepsin B, the very late
destabilization of lysosomes, which is required for the release
of cathepsin B and other cathepsins, and lack of any eﬀect of
cathepsin B ablation on apoptosis progression, suggest that
the cleavage of Bid is probably a bystander event. However,
the possibility that cysteine cathepsins, in particular cathepsin
B, may contribute to Fas/CD95 signalling through an ampliﬁ-
cation loop involving mitochondria cannot be excluded.
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